1379.T
Hokuto Corporation [1379.T] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1379.T Stock Summary
Top 10 Correlated Stocks
1379.T
In the News
1379.T Financial details
Company Rating
Buy
Market Cap
58.25B
Income
1.14B
Revenue
77.7B
Book val./share
1642.38
Cash/share
432.41
Dividend
40
Dividend %
2.27%
Employees
4.2K
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
-125.03
Forward P/E
-
PEG
22.6
P/S
0.73
P/B
1.11
P/C
4.15
P/FCF
-
Quick Ratio
0.6
Current Ratio
0.87
Debt / Equity
0.6
LT Debt / Equity
0.31
-
-
EPS (TTM)
35.86
EPS next Y
-
EPS next Q
-
EPS this Y
-180.29%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
0.78%
Revenue Q/Q
31.67%
EPS Q/Q
-832.81%
-
-
-
-
SMA20
-3.64%
SMA50
2.13%
SMA100
3.92%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-1%
ROC
-0.01%
Gross Margin
20%
Oper. Margin
-1%
Profit Margin
-1%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1708.0-1940.0
52W High
-7.53%
52W Low
+5.04%
RSI
37.79
Rel Volume
0.37
Avg Volume
74.61K
Volume
27.8K
Perf Week
-3.5%
Perf Month
-0.66%
Perf Quarter
0.06%
Perf Half Y
0.79%
-
-
-
-
Beta
-0.009
-
-
Volatility
20.23%, 37.11%
Prev Close
-0.55%
Price
1794
Change
-0.33%
1379.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.99K | 2.26K | 2.36K | 2.25K | 2.31K | |
| Net income per share | 90.48 | 48.57 | 128.83 | 80.25 | -64.43 | |
| Operating cash flow per share | 271.67 | 341.92 | 334.08 | 185.59 | 147.87 | |
| Free cash flow per share | -20.58 | 255.44 | 206.62 | -144.17 | 97.99 | |
| Cash per share | 206.62 | 332.91 | 372.3 | 308.89 | 419.95 | |
| Book value per share | 1.48K | 1.6K | 1.73K | 1.73K | 1.61K | |
| Tangible book value per share | 1.47K | 1.59K | 1.72K | 1.72K | 1.61K | |
| Share holders equity per share | 1.48K | 1.6K | 1.73K | 1.73K | 1.61K | |
| Interest debt per share | 1.07K | 1.12K | 1.02K | 1.17K | 1.26K | |
| Market cap | 68.35B | 59.42B | 65.41B | 60.09B | 58.65B | |
| Enterprise value | 96.74B | 82.57B | 83.55B | 84.52B | 82.32B | |
| P/E ratio | 21.44 | 38.81 | 16.2 | 23.75 | -28.79 | |
| Price to sales ratio | 0.97 | 0.83 | 0.89 | 0.85 | 0.8 | |
| POCF ratio | 7.14 | 5.51 | 6.25 | 10.27 | 12.54 | |
| PFCF ratio | -94.28 | 7.38 | 10.1 | -13.22 | 18.93 | |
| P/B Ratio | 1.31 | 1.18 | 1.21 | 1.1 | 1.15 | |
| PTB ratio | 1.31 | 1.18 | 1.21 | 1.1 | 1.15 | |
| EV to sales | 1.38 | 1.16 | 1.13 | 1.19 | 1.13 | |
| Enterprise value over EBITDA | 8.07 | 7.19 | 6.15 | 7.89 | 14.97 | |
| EV to operating cash flow | 10.11 | 7.66 | 7.98 | 14.45 | 17.61 | |
| EV to free cash flow | -133.44 | 10.26 | 12.9 | -18.6 | 26.57 | |
| Earnings yield | 0.05 | 0.03 | 0.06 | 0.04 | -0.03 | |
| Free cash flow yield | -0.01 | 0.14 | 0.1 | -0.08 | 0.05 | |
| Debt to equity | 0.72 | 0.7 | 0.59 | 0.68 | 0.78 | |
| Debt to assets | 0.36 | 0.35 | 0.32 | 0.35 | 0.38 | |
| Net debt to EBITDA | 2.37 | 2.02 | 1.34 | 2.28 | 4.3 | |
| Current ratio | 0.89 | 1.12 | 1.15 | 1.25 | 0.81 | |
| Interest coverage | 33.05 | 43.59 | 75.15 | 25.49 | -28.9 | |
| Income quality | 2.1 | 3.71 | 1.67 | 1.6 | -2.14 | |
| Dividend Yield | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Payout ratio | 0.6 | 1.24 | 0.47 | 0.75 | -0.94 | |
| Sales general and administrative to revenue | 0.11 | 0.11 | 0.1 | 0.1 | 0.1 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -1.08 | -0.25 | -0.38 | -1.78 | -0.34 | |
| Capex to revenue | -0.15 | -0.04 | -0.05 | -0.15 | -0.02 | |
| Capex to depreciation | -1.42 | -0.38 | -0.57 | -1.49 | -0.22 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.73K | 1.32K | 2.24K | 1.77K | 1.53K | |
| ROIC | 0.03 | 0.02 | 0.04 | 0.02 | -0.03 | |
| Return on tangible assets | 0.03 | 0.02 | 0.04 | 0.02 | -0.02 | |
| Graham Net | -1.03K | -1.02K | -851.89 | -1.04K | -1.01K | |
| Working capital | -2.8B | 2.63B | 3.56B | 5.34B | -7.15B | |
| Tangible asset value | 51.67B | 50.24B | 53.89B | 54.26B | 50.74B | |
| Net current asset value | -29.11B | -24.85B | -19.22B | -23.33B | -23.15B | |
| Invested capital | 0.72 | 0.7 | 0.59 | 0.68 | 0.78 | |
| Average receivables | 7.01B | 6.3B | 5.82B | 5.88B | 6.08B | |
| Average payables | 6.1B | 6.06B | 5.87B | 5.82B | 5.98B | |
| Average inventory | 5.87B | 6.1B | 6.42B | 6.89B | 7.55B | |
| Days sales outstanding | 35.39 | 29.71 | 28.87 | 30.44 | 31.26 | |
| Days payables outstanding | 44.53 | 41.82 | 41.21 | 39.29 | 37.63 | |
| Days of inventory on hand | 43.19 | 43.82 | 46.95 | 48.36 | 48.66 | |
| Receivables turnover | 10.31 | 12.28 | 12.64 | 11.99 | 11.68 | |
| Payables turnover | 8.2 | 8.73 | 8.86 | 9.29 | 9.7 | |
| Inventory turnover | 8.45 | 8.33 | 7.77 | 7.55 | 7.5 | |
| ROE | 0.06 | 0.03 | 0.07 | 0.05 | -0.04 | |
| Capex per share | -292.24 | -86.48 | -127.46 | -329.76 | -49.88 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 703.38 | 603.94 | 531.98 | 568.2 | 747.6 | |
| Net income per share | 15.97 | -10.55 | -10.48 | -8.99 | 65.88 | |
| Operating cash flow per share | 109.67 | 119.46 | 103.37 | 98.8 | 93.05 | |
| Free cash flow per share | 109.67 | 119.46 | 103.37 | 98.8 | 93.05 | |
| Cash per share | 341.63 | 470.75 | 477.68 | 457.89 | 432.41 | |
| Book value per share | 1.62K | 1.61K | 1.58K | 1.58K | 1.64K | |
| Tangible book value per share | 1.61K | 1.6K | 1.57K | 1.58K | 1.64K | |
| Share holders equity per share | 1.62K | 1.61K | 1.58K | 1.58K | 1.64K | |
| Interest debt per share | 908.04 | 1.25K | 863.44 | 1.08K | 980.01 | |
| Market cap | 59.39B | 58.73B | 58.05B | 57.7B | 55.07B | |
| Enterprise value | 77.27B | 82.4B | 66.98B | 78.62B | 72.41B | |
| P/E ratio | 29.4 | -43.96 | -43.72 | -50.61 | 6.59 | |
| Price to sales ratio | 2.67 | 3.07 | 3.45 | 3.2 | 2.32 | |
| POCF ratio | 17.12 | 15.53 | 17.73 | 18.42 | 18.66 | |
| PFCF ratio | 17.12 | 15.53 | 17.73 | 18.42 | 18.66 | |
| P/B Ratio | 1.16 | 1.15 | 1.16 | 1.15 | 1.06 | |
| PTB ratio | 1.16 | 1.15 | 1.16 | 1.15 | 1.06 | |
| EV to sales | 3.47 | 4.31 | 3.98 | 4.36 | 3.05 | |
| Enterprise value over EBITDA | 108.68 | 319.37 | -243.55 | -238.96 | 24.43 | |
| EV to operating cash flow | 22.28 | 21.79 | 20.46 | 25.1 | 24.53 | |
| EV to free cash flow | 22.28 | 21.79 | 20.46 | 25.1 | 24.53 | |
| Earnings yield | 0.01 | -0.01 | -0.01 | 0 | 0.04 | |
| Free cash flow yield | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | |
| Debt to equity | 0.56 | 0.78 | 0.55 | 0.68 | 0.6 | |
| Debt to assets | 0.28 | 0.38 | 0.26 | 0.32 | 0.3 | |
| Net debt to EBITDA | 25.16 | 91.74 | -32.44 | -63.59 | 5.85 | |
| Current ratio | 0.9 | 0.81 | 0.85 | 0.87 | 0.96 | |
| Interest coverage | 54.88 | 4.26 | -43.03 | -20.77 | 106.59 | |
| Income quality | 6.87 | -11.32 | -9.86 | -10.99 | 1.41 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | -0.24 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 762.55 | 618.08 | 609.79 | 565.7 | 1.56K | |
| ROIC | 0.01 | 0 | -0.02 | -0.01 | 0.03 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | 0.02 | |
| Graham Net | -961.91 | -958.63 | -1.05K | -936.53 | -856.63 | |
| Working capital | -3.01B | -7.15B | -5.67B | -4.51B | -1.47B | |
| Tangible asset value | 50.94B | 50.74B | 49.74B | 49.98B | 51.92B | |
| Net current asset value | -23.47B | -23.15B | -23.82B | -23.61B | -20B | |
| Invested capital | 0.56 | 0.78 | 0.55 | 0.68 | 0.6 | |
| Average receivables | 7.56B | 7.39B | 5.96B | 6.99B | 8.69B | |
| Average payables | 6.64B | 6.53B | 6.07B | 6.13B | 6.48B | |
| Average inventory | 8.77B | 8.26B | 8.3B | 8.82B | 8.68B | |
| Days sales outstanding | 34.51 | 29.42 | 30.26 | 41.58 | 34.35 | |
| Days payables outstanding | 37.51 | 37.02 | 37.7 | 38.04 | 37.74 | |
| Days of inventory on hand | 46.51 | 47.86 | 54.34 | 54.62 | 47.12 | |
| Receivables turnover | 2.61 | 3.06 | 2.97 | 2.16 | 2.62 | |
| Payables turnover | 2.4 | 2.43 | 2.39 | 2.37 | 2.38 | |
| Inventory turnover | 1.93 | 1.88 | 1.66 | 1.65 | 1.91 | |
| ROE | 0.01 | -0.01 | -0.01 | -0.01 | 0.04 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
1379.T Frequently Asked Questions
What is Hokuto Corporation stock symbol ?
Hokuto Corporation is a JP stock and trading under the symbol 1379.T
What is Hokuto Corporation stock quote today ?
Hokuto Corporation stock price is $1794 today.
Is Hokuto Corporation stock public?
Yes, Hokuto Corporation is a publicly traded company.
Company Profile
- Volume Average 74.61K
- Market Capitalization 58.25B
- Employee 4.2K
- CEO Mr. Masayoshi Mizuno
- Headquarters Nagano,JP
- IPO Date 2001-01-04
-
Website
https://www.hokto-kinoko.co.jp 
Hokuto Corporation researches, develops, produces, and sells mushrooms in Japan. It offers various mushrooms, including Eryngii, Maitake, Bunashimeji, Bunapi, and Shimofuri Hiratake. The company also molds and sells plastic products; produces and sells agricultural production materials and machines; and produces, processes, and sells agriculture products. It also operates in the United States, Taiwan, and Malaysia. The company was formerly known as Hokuto Industry Corporation and changed its name to Hokuto Corporation in October 2003. Hokuto Corporation was founded in 1964 and is headquartered in Nagano, Japan.
